Purpose: The purpose of this research was to examine the effects of Persicaria lapathifolia (Pale smartweed) leaf and bark extracts prepared with methanol on in vitro activities like antioxidant, antimicrobial, anti-arthritis, anti-inflammatory, and cytotoxic, as well as on some in vivo activities like analgesic and neuropharmacological properties in animal model. Methodology: The primary method for the methanolic extract of Persicaria lapathifolia leaf (MEPLL) and methanolic extract of Persicaria lapathifolia bark (MEPLB) were investigated for phytochemical screening. It was determined to look into the plant's potential for in vitro activities, such as phytochemical screening, antioxidant, anti-arthritis, anti-inflammatory, anti-bacterial, and cytotoxic, due to the pharmaceutical interest in its component parts. Its described effects on its in vivo analgesic and neuropharmacological activities in animal models are significant compared to the standard. This research was conducted between July 2022 and November 2022 in the Stamford University Bangladesh, Dhaka, Laboratory of Physiology and Pharmacology, Department of Pharmacy, and Laboratory of Microbiology. Antioxidant, anti-arthritic, anti-inflammatory, antibacterial, cytotoxic, analgesic, and neuropharmacological activities of MEPLL and MEPLB were investigated. Phytochemical screening was performed utilizing a variety of test reagents. Antioxidant, total phenolic content, anti-arthritic, anti-inflammatory, antibacterial, and cytotoxic activities were measured at various doses using the DPPH Free Radical Scavenging Assay, the Folin-Ciocalteu technique, the Inhibition of Protein Denaturation Assay, Egg Albumin Protein Denaturation Assay, the Disk Diffusion Method, and the Brine Shrimp Lethality Bioassay. The analgesic effectiveness was evaluated by using acetic acid to elicit writhing in Swiss albino mice and then testing the animals on a hot plate. Locomotor activity was measured by open field and hole cross tests as part of the neuropharmacological investigation. Results: Research performed on MEPLL and MEPLB's phytochemical screening yielded results that revealed the presence of a variety of different phytochemical components. In comparison to MEPLL's IC50 value of 1.49 µg/mL, MEPLB's value of 30.45 µg/mL indicates its superior antioxidant activity. Both extracts demonstrated significant anti-arthritic and anti-inflammatory effectiveness in comparison to the standard drug. When compared to MEPLB, MEPLL exhibited much more antibacterial activity. In a lethality test using brine shrimp, MEPLL and MEPLB both had much higher LC50 values than the standard vincristine sulfate. Their respective values were 1.42 and 0.66 µg/mL. In contrast, MEPLL inhibited peripheral nociception in the acetic acid-induced writhing nociceptive paradigm with percent inhibitions of 60.72 and 67.56, respectively, while MEPLB inhibited 48.22 and 67.28, respectively, at the aforementioned doses. In addition, the hot plate test revealed a significant analgesic effect. The extract was also shown to have a more negative impact on motor coordination in the Open Field and Hole Cross Tests than the standard Diazepam. Conclusion: This research demonstrates a relationship between the existence of anti-oxidative, anti-arthritis, and anti-bacterial activities, as well as a strong cytotoxic, analgesic, and neuropharmacological activity, which substantiates all previously made claims against Persicaria lapathifolia.

Aims: The purpose of this research was to examine the effects of methanol-prepared leaf extracts from the Solanum americanum Mill. plant on a variety of in vitro activities, including antioxidant, anti-Arthritis, anti-inflammatory, thrombolysis, anti-bacterial, and in-vivo neuropharmacological activities. Study Design: Methanolic extract of Solanum americanum leaf (MESAL) was primarily evaluated via phytochemical screening. The potential for in vitro activities, including antioxidant, anti-arthritis, anti-inflammatory, thrombolysis, and anti-bacterial activity were determined to study due to the pharmacological interest in the plant's chemical constituent. Whether there is statistical significance to the changes seen in its in vivo neuropharmacological characteristics when tested in experimental animals. Place and Duration of Study: This research was carried out between November 2022 to January 2023 at the Laboratory of Phytochemistry and Pharmacology in the Department of Pharmacy and Laboratory of Microbiology, Stamford University Bangladesh and Bangladesh Council of Scientific and Industrial Research, Dhaka. Methodology: The plant was subjected to phytochemical screening utilizing a variety of test reagents and potential antioxidant, anti-arthritis, anti-inflammatory, thrombolytic, anti-bacterial, and neuropharmacological activities of MESAL were investigated.  Antioxidant, anti-arthritic, anti-inflammatory, thrombolytic, and antibacterial activities were tested at different doses utilizing the DPPH Free Radical Scavenging Assay, Protein Denaturation Assays, Clot Lysis, and the Disk Diffusion Method. Swiss albino mice were tested using open-field and hole-cross methods to measure their locomotion as part of the neuropharmacological study. Results: The MESAL phytochemical screening findings demonstrated that the plants' chemical compositions varied. Most antioxidant activities were found in MESA, with an IC50 of 11.73 µg/mL compared to Ascorbic acid's IC50 of 28.86 µg/mL. When compared to the standard, the percent inhibition value of MESAL's anti-arthritis activity was significantly higher. With a maximum protein denaturation value of 94.03% at a concentration of 1000µg/mL, MESAL possesses potent anti-inflammatory activity. The value of MESAL in terms of clot lysis is very significant which is 90.257%. While MESAL's antibacterial value is moderate, it is still worth considering. However, the extract was proven to be less effective than Diazepam in improving motor coordination in the Open Field and Hole Cross Tests. Conclusion: Several pathological conditions, including neurodegenerative diseases, may benefit in the future from the use of plant-derived pharmacological agents due to their neuropharmacological, antioxidant, anti-inflammatory, and anti-arthritic activity, which can replace the use of NSAIDs.

The objectives of this research were to investigate the effects of Alysicarpus vaginalis L. (Alyce clover) leaf extracts prepared with ethyl acetate and methanol on in vitro activities like antioxidant, antimicrobial and cytotoxic, as well as on some in vivo activities like analgesic and neuropharmacological properties in an animal model. Study Design: Phytochemical screening was used as the primary method of evaluation for both the ethyl acetate (EAEAV) and methanolic extract (MEAV) of Alysicarpus vaginalis (L.). Because of the pharmacological interest in the plant's constituent components, it was decided to investigate its potential on in vitro activities, such as antioxidant, cytotoxic and antibacterial. Whether or if the observed effects on its in vivo analgesic and neuropharmacological properties in animal models are statistically significant. Place and Duration of Study: This investigation was performed in